Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-406341
Filing Date
2014-11-10
Accepted
2014-11-10 17:16:18
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d801815d10q.htm 10-Q 763855
2 EX-10.1 d801815dex101.htm EX-10.1 23102
3 EX-31.1 d801815dex311.htm EX-31.1 6166
4 EX-31.2 d801815dex312.htm EX-31.2 6159
5 EX-32.1 d801815dex321.htm EX-32.1 4656
  Complete submission text file 0001193125-14-406341.txt   4618975

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acrx-20140930.xml EX-101.INS 664465
7 XBRL TAXONOMY EXTENSION SCHEMA acrx-20140930.xsd EX-101.SCH 41720
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20140930_cal.xml EX-101.CAL 47943
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20140930_def.xml EX-101.DEF 133009
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20140930_lab.xml EX-101.LAB 327680
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20140930_pre.xml EX-101.PRE 222913
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 141209786
SIC: 2834 Pharmaceutical Preparations